From Taiwan to the World: PharmaEssentia Builds a Fully Integrated Global Biopharmaceutical Company Led by Scientists Focusing on Patients

Taiwan drugmaker PharmaEssentia plans US$46 million Puerto Rico plant as it expands global reach

Taipei, Oct. 17 (CNA) Taiwan-based biopharmaceutical company PharmaEssentia Corp. is expanding its global manufacturing and commercial footprint, planning a US$46 million production facility in Puerto Rico to begin operations in 2027 while consolidating its North American business to support the international growth of its blood cancer drug ropeginterferon alfa-2b (Ropeg).

PharmaEssentia Expands Global Reach

TAIPEI, Taiwan, Oct 17 — PharmaEssentia Corporation (TWSE: 6446), a Taiwan-based biopharmaceutical company, is expanding its global presence through new drug approvals, clinical trials and overseas investments, as it seeks to bring its Taiwan-developed innovative new [...] The post PharmaEssentia Expands Global Reach appeared first on Business News This Week.